MedPath

Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)

Withdrawn
Conditions
Atrial Tachycardia (Including Atrial Flutter) Post Atrial Fibrillation Ablation or Cardiac Surgery
Registration Number
NCT03613831
Lead Sponsor
Boston Scientific Corporation
Brief Summary

This study is an observational study without any hypothesis testing. It intended to observe the clinical application of electrophysiological mapping and catheter ablation of atrial tachycardia post atrial fibrillation ablation or cardiac surgery guided with Rhythmia System.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Subject with atrial tachycardia (including atrial flutter) post atrial fibrillation ablation or cardiac surgery, which occurred at least 90 days prior to enrollment;
  2. Subject is suitable for Rhythmia system and Orion catheter according to relevant clinical guidelines and products instruction for use, per investigator's discretion
  3. Subject is age 18 or above;
  4. Subject or his/ her legal representive understands and is willing to provide the Informed Consent Form (ICF) and participate in this trail.
Exclusion Criteria
  1. Subject with atrial fibrillation only;
  2. Subject is enrolled in any other concurrent study that might interfere with this study;
  3. Women of childbearing potential who are or might be pregnant at the time of this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
target patient's type1 year

Type of atrial tachycardia post atrial fibrillation ablation or cardiac surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath